| 000 | 01744 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250513152100.0 | ||
| 264 | 0 | _c19980923 | |
| 008 | 199809s 0 0 eng d | ||
| 022 | _a0003-9985 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLaposata, M | |
| 245 | 0 | 0 |
_aCollege of American Pathologists Conference XXXI on laboratory monitoring of anticoagulant therapy: the clinical use and laboratory monitoring of low-molecular-weight heparin, danaparoid, hirudin and related compounds, and argatroban. _h[electronic resource] |
| 260 |
_bArchives of pathology & laboratory medicine _cSep 1998 |
||
| 300 |
_a799-807 p. _bdigital |
||
| 500 | _aPublication Type: Consensus Development Conference; Guideline; Journal Article; Practice Guideline; Review | ||
| 650 | 0 | 4 |
_aAnticoagulants _xadministration & dosage |
| 650 | 0 | 4 |
_aArginine _xanalogs & derivatives |
| 650 | 0 | 4 |
_aChondroitin Sulfates _xadministration & dosage |
| 650 | 0 | 4 |
_aDermatan Sulfate _xadministration & dosage |
| 650 | 0 | 4 | _aDrug Combinations |
| 650 | 0 | 4 |
_aDrug Monitoring _xmethods |
| 650 | 0 | 4 |
_aHeparin _xadministration & dosage |
| 650 | 0 | 4 |
_aHeparin, Low-Molecular-Weight _xadministration & dosage |
| 650 | 0 | 4 |
_aHeparitin Sulfate _xadministration & dosage |
| 650 | 0 | 4 | _aHirudin Therapy |
| 650 | 0 | 4 |
_aHirudins _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aPathology, Clinical _xmethods |
| 650 | 0 | 4 |
_aPipecolic Acids _xadministration & dosage |
| 650 | 0 | 4 | _aSulfonamides |
| 650 | 0 | 4 |
_aThromboembolism _xblood |
| 700 | 1 | _aGreen, D | |
| 700 | 1 | _aVan Cott, E M | |
| 700 | 1 | _aBarrowcliffe, T W | |
| 700 | 1 | _aGoodnight, S H | |
| 700 | 1 | _aSosolik, R C | |
| 773 | 0 |
_tArchives of pathology & laboratory medicine _gvol. 122 _gno. 9 _gp. 799-807 |
|
| 999 |
_c9705172 _d9705172 |
||